Insider Trading activities of Progenics Pharmaceuticals Inc insiders. , Part 3

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Progenics Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Progenics Pharmaceuticals Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Progenics Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is PGNX. The reporting company's CIK number is 835887.
The total value of stock buying since 2005 is $8,030,657.
The total value of stock sales since 2005 is $30,175,090.
The total value of stock option exercises since 2005 is $9,042,404.


Go to page:  1   2   3 

Table 2. Detailed insider stock purchases, sales, and option exercises of Progenics Pharmaceuticals Inc insiders (PGNX) , Part 3
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2007-01-29 Mckinney Robert A (Chief Financial Officer) Option Ex 4,000 4.00 16,000
2007-01-29 Baker Charles A (Director) Sale 2,500 30.02 75,050
2007-01-29 Baker Charles A (Director) Option Ex 2,500 19.50 48,750
2007-01-16 Mckinney Robert A (Chief Financial Officer) Sale 4,000 28.79 115,160
2007-01-16 Mckinney Robert A (Chief Financial Officer) Option Ex 4,000 4.00 16,000
2007-01-16 Maddon Paul J (Chief Executive Officer/CSO) Sale 12,000 28.58 342,912
2007-01-16 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 12,000 5.33 63,960
2007-01-08 Scheinberg David A (Director) Option Ex 8,000 4.00 32,000
2007-01-03 Baker Mark Robert (General Counsel) Option Ex 571 21.88 12,493
2007-01-03 Boyd Thomas A (Sr. VP, Product Dev.) Option Ex 428 21.88 9,364
2007-01-03 Kremer Alton B (VP, Clinical Research) Option Ex 686 21.88 15,009
2007-01-03 Olson William C (VP, Research & Development) Option Ex 362 21.88 7,920
2007-01-03 Mckinney Robert A (Chief Financial Officer) Sale 4,000 25.68 102,708
2007-01-03 Mckinney Robert A (Chief Financial Officer) Option Ex 4,428 12.94 57,298
2007-01-03 Maddon Paul J (Chief Executive Officer/CSO) Sale 12,000 25.68 308,124
2007-01-03 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 13,614 13.61 185,218
2007-01-03 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 643 21.88 14,068
2006-12-15 Boyd Thomas A (Sr. VP, Product Dev.) Sale 2,000 26.05 52,100
2006-12-15 Boyd Thomas A (Sr. VP, Product Dev.) Option Ex 2,000 17.19 34,380
2006-12-15 Maddon Paul J (Chief Executive Officer/CSO) Sale 12,000 26.14 313,668
2006-12-15 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 12,000 5.33 63,960
2006-12-11 Mckinney Robert A (Chief Financial Officer) Sale 4,000 27.75 110,988
2006-12-11 Mckinney Robert A (Chief Financial Officer) Option Ex 4,000 4.00 16,000
2006-12-04 Israel Robert J (Sr. VP, Medical Affairs) Sale 5,000 28.00 140,000
2006-12-04 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 5,000 4.00 20,000
2006-12-01 Scheinberg David A (Director) Sale 10,000 27.15 271,490
2006-12-01 Scheinberg David A (Director) Option Ex 10,000 4.00 40,000
2006-12-01 Maddon Paul J (Chief Executive Officer/CSO) Sale 12,000 26.83 321,996
2006-12-01 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 12,000 5.33 63,960
2006-12-01 Israel Robert J (Sr. VP, Medical Affairs) Sale 5,000 26.91 134,565
2006-12-01 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 5,000 4.00 20,000
2006-11-27 Mckinney Robert A (Chief Financial Officer) Sale 4,000 28.05 112,188
2006-11-27 Mckinney Robert A (Chief Financial Officer) Option Ex 4,000 4.00 16,000
2006-11-15 Boyd Thomas A (Sr. VP, Product Dev.) Sale 2,000 28.93 57,856
2006-11-15 Boyd Thomas A (Sr. VP, Product Dev.) Option Ex 2,000 15.41 30,814
2006-11-15 Maddon Paul J (Chief Executive Officer/CSO) Sale 12,000 29.16 349,944
2006-11-15 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 12,000 5.33 63,960
2006-11-13 Mckinney Robert A (Chief Financial Officer) Sale 4,000 29.03 116,124
2006-11-13 Mckinney Robert A (Chief Financial Officer) Option Ex 4,000 4.00 16,000
2006-11-10 Mckinney Robert A (Chief Financial Officer) Sale 4,000 28.00 112,000
2006-11-10 Mckinney Robert A (Chief Financial Officer) Option Ex 4,000 4.00 16,000
2006-11-10 Israel Robert J (Sr. VP, Medical Affairs) Sale 5,000 28.00 140,000
2006-11-10 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 5,000 4.00 20,000
2006-11-01 Mckinney Robert A (Chief Financial Officer) Sale 4,000 25.96 103,856
2006-11-01 Mckinney Robert A (Chief Financial Officer) Option Ex 4,000 4.00 16,000
2006-11-01 Maddon Paul J (Chief Executive Officer/CSO) Sale 12,000 25.96 311,568
2006-11-01 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 12,000 5.33 63,960
2006-11-01 Israel Robert J (Sr. VP, Medical Affairs) Sale 5,000 25.96 129,820
2006-11-01 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 5,000 4.00 20,000
2006-10-27 Mckinney Robert A (Chief Financial Officer) Sale 4,000 26.00 104,000
2006-10-27 Mckinney Robert A (Chief Financial Officer) Option Ex 4,000 4.00 16,000
2006-10-16 Maddon Paul J (Chief Executive Officer/CSO) Sale 12,000 24.00 288,000
2006-10-16 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 12,000 5.33 63,960
2006-10-02 Baker Mark Robert (General Counsel) Option Ex 627 19.58 12,276
2006-10-02 Boyd Thomas A (Sr. VP, Product Dev.) Option Ex 470 19.58 9,202
2006-10-02 Kremer Alton B (VP, Clinical Research) Option Ex 752 19.58 14,724
2006-10-02 Olson William C (VP, Research & Development) Option Ex 397 19.58 7,773
2006-10-02 Mckinney Robert A (Chief Financial Officer) Option Ex 470 19.58 9,202
2006-10-02 Maddon Paul J (Chief Executive Officer/CSO) Sale 12,000 23.37 280,476
2006-10-02 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 13,771 12.46 171,517
2006-10-02 Israel Robert J (Sr. VP, Medical Affairs) Sale 5,000 23.37 116,865
2006-10-02 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 5,705 11.79 67,261
2006-09-15 Maddon Paul J (Chief Executive Officer/CSO) Sale 12,000 23.87 286,488
2006-09-15 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 12,000 5.33 63,960
2006-09-01 Maddon Paul J (Chief Executive Officer/CSO) Sale 12,000 22.72 272,640
2006-09-01 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 12,000 5.33 63,960
2006-09-01 Israel Robert J (Sr. VP, Medical Affairs) Sale 5,000 22.72 113,600
2006-09-01 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 5,000 4.00 20,000
2006-08-15 Maddon Paul J (Chief Executive Officer/CSO) Sale 12,000 20.20 242,412
2006-08-15 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 12,000 5.33 63,960
2006-08-01 Maddon Paul J (Chief Executive Officer/CSO) Sale 12,000 21.57 258,840
2006-08-01 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 12,000 5.33 63,960
2006-08-01 Israel Robert J (Sr. VP, Medical Affairs) Sale 5,000 21.60 108,000
2006-08-01 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 5,000 4.00 20,000
2006-07-17 Maddon Paul J (Chief Executive Officer/CSO) Sale 12,000 21.10 253,224
2006-07-17 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 12,000 5.33 63,960
2006-07-03 Baker Mark Robert (General Counsel) Option Ex 3,056 25.01 76,430
2006-07-03 Boyd Thomas A (Sr. VP, Product Dev.) Option Ex 1,986 20.45 40,615
2006-07-03 Kremer Alton B (VP, Clinical Research) Option Ex 2,262 20.45 46,260
2006-07-03 Olson William C (VP, Research & Development) Option Ex 1,365 20.45 27,915
2006-07-03 Mckinney Robert A (Chief Financial Officer) Option Ex 2,292 20.45 46,873
2006-07-03 Maddon Paul J (Chief Executive Officer/CSO) Sale 12,000 23.84 286,044
2006-07-03 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 13,727 10.37 142,348
2006-07-03 Israel Robert J (Sr. VP, Medical Affairs) Sale 5,000 23.84 119,185
2006-07-03 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 7,216 12.22 88,215
2006-06-21 Boyd Thomas A (Sr. VP, Product Dev.) Sale 3,750 21.64 81,138
2006-06-21 Kremer Alton B (VP, Clinical Research) Sale 875 21.60 18,900
2006-06-21 Maddon Paul J (Chief Executive Officer/CSO) Sale 12,500 21.62 270,262
2006-06-21 Israel Robert J (Sr. VP, Medical Affairs) Sale 900 21.60 19,440
2006-06-20 Olson William C (VP, Research & Development) Sale 1,000 21.62 21,620
2006-06-20 Mckinney Robert A (Chief Financial Officer) Sale 3,000 21.41 64,239
2006-06-01 Maddon Paul J (Chief Executive Officer/CSO) Sale 10,000 21.83 218,340
2006-06-01 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 10,000 5.33 53,300
2006-06-01 Israel Robert J (Sr. VP, Medical Affairs) Sale 5,000 21.84 109,220
2006-06-01 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 5,000 4.00 20,000
2006-05-15 Maddon Paul J (Chief Executive Officer/CSO) Sale 10,000 20.91 209,090
2006-05-15 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 10,000 5.33 53,300
2006-05-05 Olson William C (VP, Research & Development) Sale 3,893 24.00 93,432
2006-05-05 Olson William C (VP, Research & Development) Option Ex 3,893 4.00 15,572
2006-05-04 Olson William C (VP, Research & Development) Sale 10,107 24.00 242,568
2006-05-04 Olson William C (VP, Research & Development) Option Ex 10,107 4.00 40,428
2006-05-01 Maddon Paul J (Chief Executive Officer/CSO) Sale 10,000 23.52 235,200
2006-05-01 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 10,000 5.33 53,300
2006-05-01 Israel Robert J (Sr. VP, Medical Affairs) Sale 5,000 23.51 117,550
2006-05-01 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 5,000 4.00 20,000
2006-04-17 Maddon Paul J (Chief Executive Officer/CSO) Sale 10,000 25.00 250,020
2006-04-17 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 10,000 5.33 53,300
2006-04-03 Baker Mark Robert (General Counsel) Option Ex 500 21.77 10,884
2006-04-03 Boyd Thomas A (Sr. VP, Product Dev.) Option Ex 376 21.77 8,185
2006-04-03 Kremer Alton B (VP, Clinical Research) Option Ex 611 21.77 13,300
2006-04-03 Olson William C (VP, Research & Development) Option Ex 305 21.77 6,639
2006-04-03 Mckinney Robert A (Chief Financial Officer) Option Ex 361 21.77 7,858
2006-04-03 Maddon Paul J (Chief Executive Officer/CSO) Sale 10,000 25.86 258,640
2006-04-03 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 11,490 8.62 99,009
2006-04-03 Israel Robert J (Sr. VP, Medical Affairs) Sale 5,000 26.16 130,780
2006-04-03 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 5,588 12.88 71,995
2006-03-20 Olson William C (VP, Research & Development) Sale 2,000 27.46 54,920
2006-03-20 Olson William C (VP, Research & Development) Option Ex 2,000 4.00 8,000
2006-03-15 Maddon Paul J (Chief Executive Officer/CSO) Sale 10,000 27.00 270,040
2006-03-15 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 10,000 5.33 53,300
2006-03-01 Maddon Paul J (Chief Executive Officer/CSO) Sale 10,000 29.02 290,210
2006-03-01 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 10,000 5.33 53,300
2006-03-01 Israel Robert J (Sr. VP, Medical Affairs) Sale 10,000 29.02 290,210
2006-03-01 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 10,000 4.00 40,000
2006-02-27 Mckinney Robert A (Chief Financial Officer) Sale 1,500 30.00 45,000
2006-02-27 Scheinberg David A (Director) Sale 5,000 30.02 150,100
2006-02-27 Scheinberg David A (Director) Option Ex 5,000 4.00 20,000
2006-02-21 Olson William C (VP, Research & Development) Sale 2,000 28.01 56,020
2006-02-21 Olson William C (VP, Research & Development) Option Ex 2,000 4.00 8,000
2006-02-15 Boyd Thomas A (Sr. VP, Product Dev.) Sale 10,000 28.00 280,000
2006-02-15 Boyd Thomas A (Sr. VP, Product Dev.) Option Ex 10,000 13.62 136,250
2006-02-15 Maddon Paul J (Chief Executive Officer/CSO) Sale 10,000 27.17 271,680
2006-02-15 Maddon Paul J (Chief Executive Officer/CSO) Option Ex 10,000 5.33 53,300
2006-02-15 Israel Robert J (Sr. VP, Medical Affairs) Sale 1,858 28.00 52,024
2006-02-15 Israel Robert J (Sr. VP, Medical Affairs) Option Ex 1,858 4.00 7,432
2006-02-06 Olson William C (VP, Research & Development) Sale 2,000 24.45 48,906
2006-02-06 Olson William C (VP, Research & Development) Option Ex 2,000 4.00 8,000
2006-02-01 Maddon Paul J (CSO) Sale 10,000 27.73 277,270
2006-02-01 Maddon Paul J (CSO) Option Ex 10,000 5.33 53,300
2006-02-01 Israel Robert J (SR. VP Medical Affai) Sale 8,142 27.87 226,893
2006-02-01 Israel Robert J (SR. VP Medical Affai) Option Ex 8,142 4.00 32,568
2006-01-30 Kremer Alton B (VP, Clinical Researc) Sale 8,000 27.63 221,064
2006-01-30 Kremer Alton B (VP, Clinical Researc) Option Ex 8,000 13.57 108,560
2006-01-03 Baker Mark Robert (General Counsel) Option Ex 539 20.86 11,243
2006-01-03 Boyd Thomas A (SR. VP, Product Deve) Option Ex 367 20.86 7,655
2006-01-03 Kremer Alton B (VP, Clinical Researc) Option Ex 659 20.86 13,746
2006-01-03 Olson William C (VP, Research and Dev) Option Ex 330 20.86 6,883
2006-01-03 Mckinney Robert A (Cheif Financial Officer) Option Ex 390 20.86 8,135
2006-01-03 Maddon Paul J (CSO) Option Ex 1,608 20.86 33,542
2006-01-03 Israel Robert J (SR. VP Medical Affai) Option Ex 635 20.86 13,246
2005-09-13 Israel Robert J (SR. VP Medical Affai) Sale 5,000 25.00 125,000
2005-06-21 Olson William C (VP, Research and Dev) Sale 650 20.00 13,000
2005-06-21 Maddon Paul J (CSO) Sale 6,250 20.02 125,156
2005-06-20 Boyd Thomas A (SR. VP, Product Deve) Sale 750 19.85 14,887
2005-06-20 Mckinney Robert A (Cheif Financial Officer) Sale 750 19.87 14,902
2005-06-20 Jacobson Paul F (Director) Sale 3,000 19.85 59,550
2005-06-20 Israel Robert J (SR. VP Medical Affai) Sale 750 19.87 14,902
2005-06-20 Goff Stephen P (Director) Sale 3,000 19.85 59,550
Go to page:  1   2   3 

Insider trading activities including stock purchases, stock sales, and option exercises of PGNX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Progenics Pharmaceuticals Inc (symbol PGNX, CIK number 835887) see the Securities and Exchange Commission (SEC) website.